Stem Cell Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Stem Cell stocks.

Stem Cell Stocks Recent News

Date Stock Title
May 15 BCLI BrainStorm Cell Therapeutics GAAP EPS of -$0.05 beats by $0.02
May 15 BRTX BioRestorative Therapies (NASDAQ:BRTX) Announces Commercial Agreement With Cartessa, Further Expanding Into $75.46 Billion Aesthetics Market
May 15 ATNM Actinium to Host KOL Webinar to Discuss Iomab-ACT Commercial CAR T-Cell Therapy Trial Design, Objectives and Potential Market Opportunity
May 15 ALLO Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
May 15 BRTX BioRestorative Therapies reports Q1 results
May 15 BCDA BioCardia Inc (BCDA) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress Amid ...
May 15 BCDA BioCardia, Inc. (BCDA) Q1 2024 Earnings Call Transcript
May 14 BRTX BioRestorative Therapies, Inc. (BRTX) Q1 2024 Earnings Call Transcript
May 14 ATNM Actinium Announces Oral Presentation Detailing Improved Survival Outcomes in TP53 Positive Patients at the EHA 2024 Annual Congress and Presentation of Long-Term Efficacy Results in Older Patients Receiving an Iomab-B Led Bone Marrow Transplant in the ...
May 14 BCLI BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
May 14 BCDA BioCardia GAAP EPS of -$0.09, revenue of $0.05M
May 14 BRTX BioRestorative Therapies Provides First Quarter 2024 Business Update
May 14 BCDA BioCardia Reports First Quarter 2024 Business Highlights and Financial Results
May 14 ALLO Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
May 14 BCDA Most Shareholders Will Probably Find That The Compensation For BioCardia, Inc.'s (NASDAQ:BCDA) CEO Is Reasonable
May 14 ALLO Allogene Therapeutics Inc (ALLO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
May 13 ALLO Allogene Therapeutics, Inc. (ALLO) Q1 2024 Earnings Call Transcript
May 13 ALLO Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates
May 13 ALLO Allogene Therapeutics announces pricing of $110M offering of common stock
May 13 ALLO Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
Stem Cell

Stem cells are cells that can differentiate into other types of cells, and can also divide in self-renewal to produce more of the same type of stem cells.
In mammals, there are two broad types of stem cells: embryonic stem cells, which are isolated from the inner cell mass of blastocysts, and adult stem cells, which are found in various tissues. In adult organisms, stem cells and progenitor cells act as a repair system for the body, replenishing adult tissues. In a developing embryo, stem cells can differentiate into all the specialized cells—ectoderm, endoderm and mesoderm (see induced pluripotent stem cells)—but also maintain the normal turnover of regenerative organs, such as blood, skin, or intestinal tissues.
There are three known accessible sources of autologous adult stem cells in humans:
bone marrow, adipose tissue, and blood. Stem cells can also be taken from umbilical cord blood just after birth. Of all stem cell types, autologous harvesting involves the least risk. By definition, autologous cells are obtained from one's own body, just as one may bank his or her own blood for elective surgical procedures.
Adult stem cells are frequently used in various medical therapies (e.g., bone marrow transplantation). Stem cells can now be artificially grown and transformed (differentiated) into specialized cell types with characteristics consistent with cells of various tissues such as muscles or nerves. Embryonic cell lines and autologous embryonic stem cells generated through somatic cell nuclear transfer or dedifferentiation have also been proposed as promising candidates for future therapies. Research into stem cells grew out of findings by Ernest A. McCulloch and James E. Till at the University of Toronto in the 1960s.

Browse All Tags